TechLab, Inc. develops, manufactures, and distributes rapid non-invasive intestinal diagnostics. It focuses on enteric disease and microbiology of the intestinal tract, and scope of study includes markers of intestinal inflammation, the toxins of Clostridium difficile, amebiasis, and vaccine development. It offers diagnostic tests for colitis, parasitology, intestinal inflammation, and Shiga toxins of enterohemorrhagic E. coli. The company was founded by Tracy Wilkins in 1989 and is headquartered in Blacksburg, VA.

Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research & development, manufacture, and sale of pharmaceutical products as well as veterinary medicines. Its products include active pharmaceutical ingredients and generic drugs. The company was founded in 1956 and is headquartered in Taizhou, China.

NCPC New Drug Research & Development Co. Ltd., a subsidiary of Province of Hebei, is a Chinese company located in Shijiazhuang. The firm manufactures and distributes medicines.

Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.

Borui Biomedicine (Suzhou) Co., Ltd., established on 2001-10-26, Business scope includes research and development of macrolides,polypeptide,polysaccharide,Heterocycle,Azole,Azines,Phenyl ethers,Tetracyclines,Production of non-pharmaceutical macrolides,polypeptide,polysaccharide,Heterocycle,Azole,Azines,Phenyl ethers,Tetracyclines,Sell ​​the products produced by the company,And provide relevant technical consultation and technical services(Does not involve the scope of drug production license management and the restricted and prohibited products in the national foreign investment industry guidance catalog).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Drug import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Concord Biotech Ltd. operates as a research and development based biotechnology company. It manufactures active pharmaceutical ingredients through the process of fermentation, semi-synthetic and synthetic processes. The firm''s products include APIs in the immunosuppressant, antibiotic, oncology, antifungal and hypolipemic segments and enzymes. The company was founded in 2000 and is headquartered in Ahmedabad, India.

China State Institute of Pharmaceutical Industry is a Chinese company located in Shanghai and ultimately controlled by the Government of China. The firm regulates pharmaceutical companies.

Hangzhou Huadong Pharmaceutical Group New Drug Research Institute Co., Ltd., established on 2002-06-12, Business scope includes licensed projects:Internet Information Service for Medical Devices;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Cosmetics Wholesale;Cosmetics Retail;internet sales(Except for products that require a license for sale);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class II Medical Devices;Production of Class I Medical Devices;Sales of Class I Medical Devices;Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;Pharmaceutical special equipment sales;Remote Health Management Services;Internet of things technology research and development;R&D of industrial enzyme preparations;Technology Import and Export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Chongqing Qiantai Biopharmaceutical Co., Ltd., established on 2011-09-06, Business scope includes general items:Technology research and development of biomedical products,technology transfer,technical consulting,Technical Services;Pharmaceutical Intermediates(Free of chemical hazards,Psychological narcotics and other items that have special regulations in the country)research and development,Sales and technical consultation,Technical Services;Import and export,Technology Import and Export.[business law,Operation prohibited by administrative regulations;law,Projects subject to approval under administrative regulations,Must be approved in accordance with the law before operating]**(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

BrightGene Bio-Medical Technology Co., Ltd. engages in the research, development, and manufacturing of biopharmaceuticals, medicines as well as special generic active pharmaceutical ingredients and finished dosage forms. The company was founded by Jian Dong Yuan on October 26, 2001 and is headquartered in Suzhou, China.

Suzhou Haike Medical Technology Co., Ltd., established on 2015-01-14, Business scope includes biotechnology development,Bioassay Technology Services,account Serive.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Tianjin Hankang Pharmaceutical Biotechnology Co., Ltd. is a high-tech enterprise with independent intellectual property rights and specialized in R&D, production and sales of pharmaceuticals. In 2009, he was awarded the title of “Tianjin Enterprise Technology Center”. In 2013, he was included in the list of small giant growth companies that the mayor focused on. In 2014, Hankang R&D Center was named “Tianjin Key Laboratory of Enterprises”. 　　Hankang is mainly engaged in the research of new chemical drugs, and the technical sources are all independent research and development. The company has a professional research team, technicians are all undergraduate or above, and at the same time employ many well-known domestic and foreign experts as technical consultants, scientific research results are remarkable. At present, more than 180 products have been successfully developed, more than 40 new drug certificates, more than 90 clinical approvals for new drugs, and more than 40 production approvals. He applied for more than 140 invention patents and obtained more than 60 invention patent certificates. He was awarded Tianjin Tianjin Invention Patent Pilot Enterprise twice.

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Sinopharm Group Health Industry Research Institute Co., Ltd., established on 2013-12-26, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Technology intermediary service;Biochemical product technology research and development;Bio-feed R&D;Health Consulting Services(Does not include medical services);Drug testing equipment sales;Cosmetics Wholesale;Daily necessities wholesale;Pet Food and Supplies Wholesale;internet sales(Except for products that require a license for sale);Sales of hygiene products and single-use medical products;Sales of Class I Medical Devices;Sales of Class II Medical Devices;food sales(Only sell prepackaged food);Food Internet Sales(Only sell prepackaged food);Healthy food(prepackaged)Sales;Sales of formula food for special medical purposes.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Olon is one of the largest European developers and manufacturers, supplying APIs for the pharmaceutical industry worldwide both, for Generic as well as for contract manufacturing. OLON owns 5 manufacturing sites in northern Italy (Rodano, Settimo Torinese, Garbagnate Milanese, Mulazzano and Dorno) with more than 800 employees while INFA Group, with more than 400 employees, has 2 manufacturing sites in Italy, Labochim and Sifavitor, and 1 in Spain, Derivados Químicos.

Borui Biomedicine Taixing Co., Ltd., established on 2007-01-26, The business scope includes biological raw materials(Newmocontin,Acarbose,Vancomycin,Epothilone,Daptomycin,Ademetionine,Ascomycin,Sirolimus,Nondamicin,Caspofungin,Micafungin,Anifungin,Pimecrolimus),posaconazole,pemetrexed,Entecavir,Manufacturing of Fondaparinux Sodium,Sales;Chemical Product Research,to develop(No processing),Chemical Technology Development,Technical Services;chemical product,Liquid crystal intermediate sales(The above does not contain hazardous chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)(The company is a licensed enterprise)

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.